Related Experiment Video
Updated: Jul 4, 2025
Manipulation of Ploidy in Caenorhabditis elegans
Published on: March 15, 2018
Polyploidy in Cancer: Causal Mechanisms, Cancer-Specific Consequences, and Emerging Treatments
Patrick J Conway1,2, Jonathan Dao1,3, Dmytro Kovalskyy4
1Mays Cancer Center, University of Texas Health San Antonio, San Antonio, Texas.
Abstract:
Drug resistance is the major determinant for metastatic disease and fatalities, across all cancers. Depending on the tissue of origin and the therapeutic course, a variety of biological mechanisms can support and sustain drug resistance. Although genetic mutations and gene silencing through epigenetic mechanisms are major culprits in targeted therapy, drug efflux and polyploidization are more global mechanisms that prevail in a broad range of pathologies, in response to a variety of treatments. There is an unmet need to identify patients at risk for polyploidy, understand the mechanisms underlying polyploidization, and to develop strategies to predict, limit, and reverse polyploidy thus enhancing efficacy of standard-of-care therapy that improve better outcomes. This literature review provides an overview of polyploidy in cancer and offers perspective on patient monitoring and actionable therapy.
Insights
Polyploidy, a condition where cells have multiple sets of chromosomes, contributes to cancer drug resistance and poor outcomes. Understanding and targeting polyploidy could improve cancer therapies.
Area of Science:
- Oncology
- Cell Biology
- Genetics
Background:
- Drug resistance is a primary driver of cancer metastasis and mortality.
- Mechanisms of drug resistance include genetic mutations, epigenetic silencing, drug efflux, and polyploidization.
- Polyploidy is a global mechanism of resistance observed across various cancers and treatments.
Purpose of the Study:
- To review the role of polyploidy in cancer drug resistance.
- To highlight the need for identifying at-risk patients and understanding polyploidization mechanisms.
- To discuss strategies for predicting, limiting, and reversing polyploidy to improve cancer therapy efficacy.
Main Methods:
- Literature review of polyploidy in cancer.
- Analysis of biological mechanisms underlying drug resistance.
- Exploration of patient monitoring and therapeutic strategies.
Main Results:
- Polyploidy is a significant contributor to multifaceted drug resistance in cancer.
- Current therapeutic strategies often fail to address polyploidy effectively.
- There is a critical need for novel approaches to manage polyploidy-associated resistance.
Conclusions:
- Polyploidy presents a significant challenge in overcoming cancer drug resistance.
- Developing methods to identify, predict, and reverse polyploidy is crucial.
- Targeting polyploidy offers a promising avenue for enhancing standard-of-care cancer therapies and improving patient outcomes.
Related Concept Videos
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:18Cancer
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:21Cancers Originate from Somatic Mutations in a Single Cell
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:21Nondisjunction